Probiotics, Prebiotics, and Lactoferrin-Implications for Preterm Mortality and Morbidity
JAMA Pediatr
.
2023 Nov 1;177(11):1129-1131.
doi: 10.1001/jamapediatrics.2023.3856.
Authors
Mohan Pammi
1
,
Barbara B Warner
2
,
Ravi Mangal Patel
3
Affiliations
1
Baylor College of Medicine and Texas Children's Hospital, Houston.
2
Washington University School of Medicine, St Louis, Missouri.
3
Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia.
PMID:
37782507
DOI:
10.1001/jamapediatrics.2023.3856
No abstract available
Publication types
Comment
MeSH terms
Humans
Infant, Newborn
Infant, Premature
Lactoferrin
Morbidity
Prebiotics*
Probiotics* / therapeutic use
Substances
Prebiotics
Lactoferrin
Grants and funding
R01 HD112886/HD/NICHD NIH HHS/United States